Weihong Hu
About
In The Last Decade
Weihong Hu
16 papers receiving 365 citations
Peers
Comparison fields: 5 of 61
- Reproductive Medicine 249
- Public Health, Environmental and Occupational Health 170
- Molecular Biology 135
- Cardiology and Cardiovascular Medicine 41
- Immunology 35
Countries citing papers authored by Weihong Hu
This map shows the geographic impact of Weihong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihong Hu more than expected).
Fields of papers citing papers by Weihong Hu
This network shows the impact of papers produced by Weihong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihong Hu. The network helps show where Weihong Hu may publish in the future.
Co-authorship network of co-authors of Weihong Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Weihong Hu. A scholar is included among the top collaborators of Weihong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihong Hu. Weihong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 24 | |
| 5 | 52 | |
| 6 | 1 | |
| 7 | [Expression of PPARγ mRNA in granulosa cells and its correlation with clinical characteristics of polycystic ovary syndrome]. | 2 |
| 8 | 34 | |
| 9 | 131 | |
| 10 | 33 | |
| 11 | 45 | |
| 12 | [Clinical features of the metabolic syndrome in patients with polycystic ovary syndrome]. | 4 |
| 13 | [Characteristics of abnormal glucose tolerance in patients with polycystic ovary syndrome]. | 2 |
| 14 | [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases]. | 6 |
| 15 | [Relations of serum adipocyte fatty acid binding protein to sex hormone and lipoproteins in patients with polycystic ovary syndrome]. | 5 |
| 16 | [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome]. | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.